KKR launches Allyntra, a precision-engineered medtech platform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- S&P Global explores potential separation of Capital IQ business
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
KKR Launches Allyntra, an Engineered Solutions Platform for Medical Technology and Precision Industries
July 9, 2026 6:59 AM EDTRobbie Atkinson appointed as CEO and Brian Highley appointed as Chairman
NEW YORK--(BUSINESS WIRE)-- KKR today announced the launch of Allyntra (Allyntra or the Company), a newly formed precision-engineered solutions platform serving medical technology and other precision end markets. Allyntra builds on KKRs existing investment in Precipart through its Health Care Strategic Growth Fund II, with Precipart serving as one of the foundational businesses within the platform. KKR is committing meaningful additional capital to support Allyntras growth by acquiring and integrating complementary best-in-class businesses and through continued investment in innovation and commercial... More



